ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC12917-100mg |
|
103-90-2 |
Acetaminophen
|
0 | C8H9NO2 | |
GC12917-10mM (in 1mL DMSO) |
|
103-90-2 |
Acetaminophen
|
0 | C8H9NO2 | |
GC12916-50mg |
|
191931-56-3 |
NTNCB hydrochloride
|
0 | C25H33N3O4S.HCl | |
GC12916-10mg |
|
191931-56-3 |
NTNCB hydrochloride
|
0 | C25H33N3O4S.HCl | |
GC12914-1mg |
|
145782-74-7 |
AR-C 66096 tetrasodium salt
|
0 | C14H18F2N5Na4O12P3S | |
GC12913-50mg |
|
65-61-2 |
Acridine Orange hydrochloride
|
0 | C17H19N3.HCl | |
GC12912-50mg |
|
406191-34-2 |
BCATc Inhibitor 2
|
0 | C16H10ClF3N2O4S | |
GC12912-10mg |
|
406191-34-2 |
BCATc Inhibitor 2
|
0 | C16H10ClF3N2O4S | |
GC12912-5mg |
|
406191-34-2 |
BCATc Inhibitor 2
|
0 | C16H10ClF3N2O4S | |
GC12912-1mg |
|
406191-34-2 |
BCATc Inhibitor 2
|
0 | C16H10ClF3N2O4S | |
GC12911-10mM (in 1mL DMSO) |
|
136-47-0 |
Tetracaine HCl
|
0 | C15H24N2O2.HCl | |
GC12911-50mg |
|
136-47-0 |
Tetracaine HCl
|
0 | C15H24N2O2.HCl | |
GC12910-10mM (in 1mL DMSO) |
|
267243-28-7 |
Canertinib (CI-1033)
|
0 | C24H25ClFN5O3 | |
GC12910-100mg |
|
267243-28-7 |
Canertinib (CI-1033)
|
0 | C24H25ClFN5O3 | |
GC12910-50mg |
|
267243-28-7 |
Canertinib (CI-1033)
|
0 | C24H25ClFN5O3 | |
GC12910-10mg |
|
267243-28-7 |
Canertinib (CI-1033)
|
0 | C24H25ClFN5O3 | |
GC12909-250mg |
|
37762-06-4 |
Zaprinast
|
0 | C13H13N5O2 | |
GC12909-100mg |
|
37762-06-4 |
Zaprinast
|
0 | C13H13N5O2 | |
GC12909-10mg |
|
37762-06-4 |
Zaprinast
|
0 | C13H13N5O2 | |
GC12909-50mg |
|
37762-06-4 |
Zaprinast
|
0 | C13H13N5O2 | |